A5057411375- Thyroid Cancer Diagnosis and Treatment
- Thyroid and Parathyroid Surgery
- Thyroid Disorders and Treatments
- Neuroendocrine Tumor Research Advances
- Head and Neck Anomalies
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Pituitary Gland Disorders and Treatments
- Radiopharmaceutical Chemistry and Applications
- Radiation Dose and Imaging
- Medical Imaging and Pathology Studies
- Lymphoma Diagnosis and Treatment
- Salivary Gland Tumors Diagnosis and Treatment
- Adrenal and Paraganglionic Tumors
- Neuroblastoma Research and Treatments
- Prostate Cancer Treatment and Research
- Parathyroid Disorders and Treatments
- S100 Proteins and Annexins
- BRCA gene mutations in cancer
- Lung Cancer Research Studies
- Sarcoma Diagnosis and Treatment
- Cardiac tumors and thrombi
- Lung Cancer Treatments and Mutations
- Prostate Cancer Diagnosis and Treatment
- Ovarian cancer diagnosis and treatment
University Hospital of Zurich
2018-2025
Clinica Luganese Moncucco
2024-2025
Ente Ospedaliero Cantonale
2013-2024
University of Zurich
2017-2024
Istituto Imaging della Svizzera Italiana
2019-2024
Institute of Oncology Research
2014-2023
Laboratory for Biomedical Neurosciences
2019-2023
European Association of Nuclear Medicine
2015-2022
Ente Ospedaliero Ospedali Galliera
2013-2021
Repubblica e Cantone Ticino
2021
Nuclear medicine parathyroid imaging is important in the identification of hyperfunctioning glands primary hyperparathyroidism (pHPT), but it may be also valuable before surgical treatment secondary (sHPT). Parathyroid radionuclide with scintigraphy or positron emission tomography (PET) a highly sensitive procedure for assessment presence and number glands, located either at typical sites ectopically. The pHPT mostly directed toward minimally invasive parathyroidectomy, especially cases...
To assess the role of [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) after rituximab and anthracycline-containing chemoimmunotherapy in patients with primary mediastinal large B-cell lymphoma (PMLBCL).Among 125 prospectively enrolled, 115 were eligible for central review PET/CT scans at completion standard chemoimmunotherapy, by using a five-point scale. Consolidation radiotherapy (RT) was permitted given to 102 patients.Fifty-four (47%) achieved...
Abstract Context Radiofrequency ablation (RFA) of benign thyroid nodules has been gaining consensus. However, no solid information on its long-term efficacy is available. Objective To analyze the results single-session RFA. Design Retrospective longitudinal observational study. Setting Primary care center. Patients or Other Participants Adult outpatients who underwent a RFA and posttreatment follow-up least 3 years. Intervention Ultrasound-guided was performed after local anesthesia by...
Background Ultrasound (US) risk stratification systems (RSSs) have been developed to reduce the number of unnecessary fine needle aspirations (FNAs) thyroid nodules. These were designed primarily identify papillary carcinomas, thus their performance on follicular carcinoma (FTC) is debatable. The present study was undertaken investigate accuracy RSSs in selecting FTCs for FNA. Methods Patients with FTC who underwent US examinations between 2012 and 2018 2 institutions selected. images...